SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-026241
Filing Date
2023-06-05
Accepted
2023-06-05 08:25:28
Documents
12
Period of Report
2023-06-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20230603.htm   iXBRL 8-K 101355
  Complete submission text file 0000950170-23-026241.txt   216964

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20230603_pre.xml EX-101.PRE 9445
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20230603_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20230603.xsd EX-101.SCH 2457
6 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20230603_htm.xml XML 4523
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 23991303
SIC: 2834 Pharmaceutical Preparations